[Influence of serum phosphate level for effects of OCT pulse therapy in hyper-PTH HD patients].
When we treat hyper-PTH patients with OCT pulse therapy, it is easy to suppress the PTH secretion below 30 ng/mL by controlling phosphate concentration under 5 mg/dL. But in hyperphosphate (>5.0 mg/dL) cases, we can't stop or avoid the secretion of PTH by OCT pulse therapy.
Chiba
Eiichi
E
Jinyukai Iwamizawa Clinic.
Sugawara
Gotaro
G
D002117:Calcitriol / Q000008:administration & dosage / Q000031:analogs & derivatives*; D006801:Humans; D006962:Hyperparathyroidism, Secondary / Q000188:drug therapy* / Q000209:etiology; D010758:Phosphorus / Q000097:blood*; D020551:Pulse Therapy, Drug; D006435:Renal Dialysis / Q000009:adverse effects*; D012189:Retrospective Studies
D010758:Phosphorus; D002117:Calcitriol; C051883:maxacalcitol